Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 713.81 million compared to CNY 420.74 million a year ago. Revenue was CNY 713.81 million compared to CNY 420.74 million a year ago.

Net income was CNY 201.49 million compared to CNY 145.22 million a year ago. Basic earnings per share from continuing operations was CNY 1.86 compared to CNY 1.34 a year ago. Diluted earnings per share from continuing operations was CNY 1.86 compared to CNY 1.34 a year ago.